| Dr John Gerard Devlin Jr, MD | |
|
825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010-3231 | |
| (610) 527-3800 | |
| (610) 527-0334 |
| Full Name | Dr John Gerard Devlin Jr |
|---|---|
| Gender | Male |
| Speciality | Hematology |
| Experience | 23 Years |
| Location | 825 Old Lancaster Rd, Bryn Mawr, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073728663 | NPI | - | NPPES |
| 1032165360001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD423240 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Main Line Health Home Care & Hospice - Home Health | Radnor, PA | Home health agency |
| Main Line Health Homecare & Hospice - Hospice | Radnor, PA | Hospice |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bryn Mawr Medical Specialists Association | 4183610934 | 94 |
News Archive
Interventional Spine, Inc. today announced FDA clearance of its Lateral Opticage Expandable Intervertebral Body Fusion Device. This device joins the Interventional Spine family of Opticage Expandable Interbody Fusion Devices previously cleared for TLIF earlier this year, and used with the Company's PerX360 System.
Imagine having feelings of distress and negativity at some point as you are going about your day. Then imagine feeling that way every day, for almost 21 days. Lesbian, gay, bisexual, transgender and queer youth don't have to imagine having negative feelings at some point throughout the day for an extended period of days.
Plenty of hospitals and medical providers claim they do a great job at caring for patients and protecting their safety during care. But very few actually publish the cold, hard numbers that could prove those claims. And even fewer do it like the University of Michigan Health System has: on a website open to anyone, with dozens of charts and graphs showing actual performance and comparisons to national averages and benchmarks.
Treatment with a commonly used drug slows the decline in lung function in patients with chronic obstructive pulmonary disease (COPD), according to results from the TORCH (TOwards a Revolution in COPD Health) study presented at the American Thoracic Society 2007 International Conference, on Tuesday, May 22.
Janssen Research & Development, LLC (Janssen), announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of canagliflozin, an investigational, oral, once-daily, selective sodium glucose co-transporter 2 (SGLT2) inhibitor, for the treatment of adult patients with type 2 diabetes.
› Verified 7 days ago
| Entity Name | Bryn Mawr Medical Specialists Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841226099 PECOS PAC ID: 4183610934 Enrollment ID: O20040426000467 |
News Archive
Interventional Spine, Inc. today announced FDA clearance of its Lateral Opticage Expandable Intervertebral Body Fusion Device. This device joins the Interventional Spine family of Opticage Expandable Interbody Fusion Devices previously cleared for TLIF earlier this year, and used with the Company's PerX360 System.
Imagine having feelings of distress and negativity at some point as you are going about your day. Then imagine feeling that way every day, for almost 21 days. Lesbian, gay, bisexual, transgender and queer youth don't have to imagine having negative feelings at some point throughout the day for an extended period of days.
Plenty of hospitals and medical providers claim they do a great job at caring for patients and protecting their safety during care. But very few actually publish the cold, hard numbers that could prove those claims. And even fewer do it like the University of Michigan Health System has: on a website open to anyone, with dozens of charts and graphs showing actual performance and comparisons to national averages and benchmarks.
Treatment with a commonly used drug slows the decline in lung function in patients with chronic obstructive pulmonary disease (COPD), according to results from the TORCH (TOwards a Revolution in COPD Health) study presented at the American Thoracic Society 2007 International Conference, on Tuesday, May 22.
Janssen Research & Development, LLC (Janssen), announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of canagliflozin, an investigational, oral, once-daily, selective sodium glucose co-transporter 2 (SGLT2) inhibitor, for the treatment of adult patients with type 2 diabetes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Gerard Devlin Jr, MD 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010-3231 Ph: (610) 527-3800 | Dr John Gerard Devlin Jr, MD 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010-3231 Ph: (610) 527-3800 |
News Archive
Interventional Spine, Inc. today announced FDA clearance of its Lateral Opticage Expandable Intervertebral Body Fusion Device. This device joins the Interventional Spine family of Opticage Expandable Interbody Fusion Devices previously cleared for TLIF earlier this year, and used with the Company's PerX360 System.
Imagine having feelings of distress and negativity at some point as you are going about your day. Then imagine feeling that way every day, for almost 21 days. Lesbian, gay, bisexual, transgender and queer youth don't have to imagine having negative feelings at some point throughout the day for an extended period of days.
Plenty of hospitals and medical providers claim they do a great job at caring for patients and protecting their safety during care. But very few actually publish the cold, hard numbers that could prove those claims. And even fewer do it like the University of Michigan Health System has: on a website open to anyone, with dozens of charts and graphs showing actual performance and comparisons to national averages and benchmarks.
Treatment with a commonly used drug slows the decline in lung function in patients with chronic obstructive pulmonary disease (COPD), according to results from the TORCH (TOwards a Revolution in COPD Health) study presented at the American Thoracic Society 2007 International Conference, on Tuesday, May 22.
Janssen Research & Development, LLC (Janssen), announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of canagliflozin, an investigational, oral, once-daily, selective sodium glucose co-transporter 2 (SGLT2) inhibitor, for the treatment of adult patients with type 2 diabetes.
› Verified 7 days ago
Dr. Sameer Gupta, MD, MPH Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-3800 Fax: 610-527-0334 | |
Kellie Ann Matson, PA-C Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 484-337-3000 | |
John Steers, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-1165 Fax: 610-527-6611 | |
Dr. Clarke U. Piatt, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-3800 Fax: 610-527-0334 | |
Francis P. Day, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-3800 Fax: 610-527-0334 | |
Robert R Atkins, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-3800 Fax: 610-527-0334 | |
Dr. Sophia Moldavsky, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 830 Old Lancaster Rd Ste 206, Bryn Mawr, PA 19010 Phone: 610-525-8110 |